Literature DB >> 25793577

Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Alexander Berndt1, Petra Richter, Hartwig Kosmehl, Marcus Franz.   

Abstract

Carcinoma invasion is a complex process regulated by genetic and epigenetic factors as well. A relevant supportive condition for cancer cell migration is the reorganization of the extracellular matrix (ECM), which is realized in an orchestrated multicellular manner including carcinoma cells and stromal fibroblasts. An important key player in the process of ECM reorganization is Tenascin-C (Tn-C). The molecule occurs as different isoforms generated by alternative splicing and de novo glycosylation. Large variants of Tn-C are abundantly re-expressed in the invasive front of many carcinoma types. A special role for initiating migration and accompanied epithelial to mesenchymal transition has been suggested. Here, we review the current knowledge concerning the tumor biological importance of Tn-C, the synthesis and alternative splicing during the invasive process in general, and give an overview on the impact of Tn-C in urothelial carcinoma of the urinary bladder (UBC) and oral squamous cell carcinoma (OSCC).

Entities:  

Keywords:  3D, 3 dimensional; BM, basement membane; CAF, cancer associated fibroblast; ECM reorganization; ECM, extracellular matrix; EMT, epithelial – mesenchymal transition; FGF2, fibroblast growth factor 2; FNIII, fibronectin type III like repeats; Fn, fibronectin; Ln, laminin; Lnγ2, laminin gamma 2 chain; MMP, matrix metalloproteinase; OSCC, oral squamous cell carcinoma; PDGF, platelet derived growth factor; RNA, ribonucleic acid; TGFβ1, transforming growth factor beta 1; TPA, tetradecanoylphorbol acetate; Tn-C, tenascin-C; UBC, urothelial carcinoma of the urinary bladder; alternative splicing; carcinoma invasion; hnRNPs, heterogeneous nuclear ribonucleoproteins; mRNA, messenger RNA; oncFn, oncofetal fibronectin; oncTn-C, oncofetal tenascin-C; oral squamous cell carcinoma; tenascin-C; urothelial carcinoma of the urinary bladder

Mesh:

Substances:

Year:  2015        PMID: 25793577      PMCID: PMC4422813          DOI: 10.1080/19336918.2015.1005463

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  82 in total

Review 1.  The extracellular matrix: an active or passive player in fibrosis?

Authors:  Thomas N Wight; Susan Potter-Perigo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

2.  Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix.

Authors:  Dongmin Dang; Yongjian Yang; Xiaowu Li; Amha Atakilit; Joseph Regezi; David Eisele; Duncan Ellis; Daniel M Ramos
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

Review 3.  Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

Authors:  G J Thomas; M L Nyström; J F Marshall
Journal:  J Oral Pathol Med       Date:  2006-01       Impact factor: 4.253

4.  Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor.

Authors:  I Aukhil; C C Slemp; V A Lightner; K Nishimura; G Briscoe; H P Erickson
Journal:  Matrix       Date:  1990-05

Review 5.  The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.

Authors:  F S Jones; P L Jones
Journal:  Dev Dyn       Date:  2000-06       Impact factor: 3.780

6.  Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.

Authors:  N Dandachi; C Hauser-Kronberger; E Moré; B Wiesener; G W Hacker; O Dietze; G Wirl
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

Review 7.  Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Circ J       Date:  2012-10-13       Impact factor: 2.993

8.  Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.

Authors:  Enrico Martina; Martin Degen; Curzio Rüegg; Adrian Merlo; Maddalena M Lino; Ruth Chiquet-Ehrismann; Florence Brellier
Journal:  FASEB J       Date:  2009-11-02       Impact factor: 5.191

9.  Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.

Authors:  P Shrestha; F Sakamoto; H Takagi; T Yamada; M Mori
Journal:  Eur J Cancer B Oral Oncol       Date:  1994

10.  Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.

Authors:  S Deen; R Y Ball
Journal:  Histopathology       Date:  1994-11       Impact factor: 5.087

View more
  13 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

2.  Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.

Authors:  Haiyan Fu; Yuan Tian; Lili Zhou; Dong Zhou; Roderick J Tan; Donna B Stolz; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

Review 3.  Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.

Authors:  Lukas Lacina; Jan Plzak; Ondrej Kodet; Pavol Szabo; Martin Chovanec; Barbora Dvorankova; Karel Smetana
Journal:  Int J Mol Sci       Date:  2015-10-12       Impact factor: 5.923

4.  Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.

Authors:  Keiichi Koshizuka; Nijiro Nohata; Toyoyuki Hanazawa; Naoko Kikkawa; Takayuki Arai; Atsushi Okato; Ichiro Fukumoto; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2017-05-02

Review 5.  The microbiome in urological diseases.

Authors:  Kwang Woo Lee; Ho Yeon Song; Young Ho Kim
Journal:  Investig Clin Urol       Date:  2020-06-24

Review 6.  Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.

Authors:  Takuya Iyoda; Motomichi Fujita; Fumio Fukai
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

7.  An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma.

Authors:  Samapika Routray; Ravindra Kumar; Keshava K Datta; Vinuth N Puttamallesh; Aditi Chatterjee; Harsha Gowda; Neeta Mohanty; Rupesh Dash; Anshuman Dixit
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 8.  The interplay of extracellular matrix and microbiome in urothelial bladder cancer.

Authors:  Massimo Alfano; Filippo Canducci; Manuela Nebuloni; Massimo Clementi; Francesco Montorsi; Andrea Salonia
Journal:  Nat Rev Urol       Date:  2015-12-15       Impact factor: 14.432

9.  Effects of Tenascin C on the Integrity of Extracellular Matrix and Skin Aging.

Authors:  Young Eun Choi; Min Ji Song; Mari Hara; Kyoko Imanaka-Yoshida; Dong Hun Lee; Jin Ho Chung; Seung-Taek Lee
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

10.  Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.

Authors:  Xiangyi Kong; Wenbin Ma; Yongning Li; Yu Wang; Jian Guan; Jun Gao; Junji Wei; Yong Yao; Wei Lian; Zhiqin Xu; Wanchen Dou; Bing Xing; Zuyuan Ren; Changbao Su; Yi Yang; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.